Sorry, no content matched your criteria.
Featured Story
Penny Stock News: Why This Stock’s 28% Run Will Continue
Shares of drug companies developing Ebola treatments have at turns soared and tanked over the past couple months amid speculation and hype.
But other companies not chasing after a treatment for the disease have also attracted interest amid the worst Ebola outbreak in history. One such company is Alpha Pro Tech (NYSEMKT: APT), which made penny stock news in October when shares soared to an all-time high of $10.73.
Here's a look at why APT is more than just an Ebola stock...
Shares of drug companies developing Ebola treatments have at turns soared and tanked over the past couple months amid speculation and hype.
But other companies not chasing after a treatment for the disease have also attracted interest amid the worst Ebola outbreak in history. One such company is Alpha Pro Tech (NYSEMKT: APT), which made penny stock news in October when shares soared to an all-time high of $10.73.
Here's a look at why APT is more than just an Ebola stock...